• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Employment/Membership › Details

CureVac–Bronsema V: board, 202008– Supervisory Board Member nominated by KfW main org BIO Deutschland

 

	Period	2020-12-23
	Organisation	CureVac N.V. (Nasdaq: CVAC)
	Organisation 2	Kreditanstalt für Wiederaufbau (KfW)
	Group	Germany (govt)
	Product	mRNA technology
	Product 2	business development (state/region)
	Person	Bronsema, Viola (BIO Deutschland 200905 Managing Director + CureVac 202008– Supervisory Board Member)

CureVac N.V.. (12/23/20). Web Site: Leadership – Executive Board, Supervisory Board and Scientific Advisory Board. [https://www.curevac.com, 12/23/20]

Record changed: 2020-12-28

Advertisement

More documents for CureVac N.V. (Nasdaq: CVAC)

• [1] CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA....
• [2] CureVac N.V.. (12/23/20). Web Site: Leadership – Executive Board, Supervisory Board and Scientific Advisory Board. [https://www.curevac.com, 12/23/20]...
• [3] CureVac N.V.. (12/9/20). "Press Release: CureVac and Fareva Sign Agreement for Fill & Finish Manufacturing of Curevac’s COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA....
• [4] CureVac N.V.. (12/4/20). "Press Release: CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer". Tübingen & Boston, MA....
• [5] Kaleido Biosciences, Inc.. (10/1/20). "Press Release: Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer". Lexington, MA....
• [6] CureVac N.V.. (9/29/20). "Press Release: CureVac Initiates Phase 2a Clinical Trial of COVID-19 Vaccine Candidate. Study Conducted in Peru and Panama". Tübingen & Boston, MA....
• [7] CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA....
• [8] CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA....
• [9] CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.